Sign In
Buy ARKG
$33.15
-0.260 (-0.778%)
At Close: Jun 08, 2026
Best Performing ETFs Of The Year
07:00am, Thursday, 24'th Dec 2020
Returns for the top performers ranged from 94% to 185%.
6 Best Active ETFs of 2020
01:32pm, Tuesday, 22'nd Dec 2020
The year 2020 has been beneficial for equities despite coronavirus outbreak. These active ETFs, however, breezed past the benchmark index.
Biotech ETFs Tracking CRISPR Gene Editing Surge
04:26pm, Monday, 21'st Dec 2020
A biotechnology exchange traded fund focusing on CRISPR gene editing bucked the broader market trends on Monday. Among the best performing non-leveraged ETFs of Monday, the ARK Genomic Revolution Mult
Best ETFs for Q1 2021
01:04pm, Wednesday, 16'th Dec 2020
The best ETFs for Q1 2021 are ARKG, TAN, and PBW.
The ARKG ETF Doesn't Need More Catalysts. It's Getting Them Anyway
11:52am, Tuesday, 15'th Dec 2020
The ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) doesn't need more catalysts, but in the rapidly evolving genomics spaces they keep on coming. ARKG is a substantial departure from the health
JPMorgan rolls out a supercharged tech trade designed to amplify gains in stocks like Tesla, report says
12:35pm, Monday, 14'th Dec 2020
Tech stocks have already led the stock market to several record highs in 2020. JPMorgan thinks investors want to double down on the sector. The bank is letting investors in on a new trade that amplifi
Falling Costs Make Genomics (and Their ETFs) More Attractive than Ever
11:53am, Wednesday, 09'th Dec 2020
One of the most compelling elements in the genomics investment thesis is that costs are declining, making the next generation of healthcare solutions more accessible. That trend also benefits financia
5 Of My Favorite ARK Positions
09:50am, Wednesday, 09'th Dec 2020
5 Of My Favorite ARK Positions
MoneyLine Podcast: These Stocks are Making MASSIVE Moves
04:13pm, Tuesday, 08'th Dec 2020
Listen in to hear how you can profit in 2021 and beyond
ARKG: Perennial Outperformance Ahead
11:54am, Thursday, 03'rd Dec 2020
ARKG aims to capitalize on a $9Tn TAM with the convergence of AI, DNA Sequencing and Gene-Editing. ARKG is up 149% YTD vs. the SPX return of 13%.
Up 144% in a Tumultuous 2020? No Surprise for ARKG
10:43am, Wednesday, 02'nd Dec 2020
Healthcare is often viewed as a defensive sector, but it's evolving, offering investors more credible avenues for growth. One of the prime avenues for tapping into that trend is the ARK Genomic Revolu
How Precision Medicine Will Revolutionize Healthcare
11:12am, Wednesday, 25'th Nov 2020
Precision medicine is in its nascent stages, but the field is rapidly growing, adding another catalyst to an already lengthy list for the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). One of
The Genomics ETF on the Front Lines of Cancer Detection
10:02am, Monday, 16'th Nov 2020
Investors seeking big-time growth potential, thematic exposure, and active management themes may want to give the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) serious consideration. ARKG incl
Ark ETFs Defying Gravity
08:23am, Monday, 09'th Nov 2020
It's been a sensational year for an ETF active manager known for contrarian conviction.
Cathie Wood Increases Teladoc Holdings Across Ark ETFs
02:06pm, Monday, 02'nd Nov 2020
The Ark ETFs from Catherine Wood are among the best performing ETFs in 2020 and the active trading could help investors follow potential winning ideas. What Happened: Wood added additional shares in
